REBA HPV-ID® for efficient genotyping of human papillomavirus in clinical samples from Korean patients

Journal of Medical Virology

Volumn 84, Issue 8, 2012, Pages 1248-1253

  Kim, Sunghyun ^a   Lee, Dongsup ^a,b   Park, Sangjung ^a   Kim, Tae Ue ^a   Jeon, Bo Young ^a   Park, Kwang Hwa ^a   Lee, Hyeyoung ^a  

^a Yonsei University Wonju   (South Korea)

^b Hyejeon University   (South Korea)

Author keywords

DNA Chip; Genotyping; Human papillomavirus; Korea; REBA HPV ID

Indexed keywords

ARTICLE; CYTODIAGNOSIS; DNA MICROARRAY; FEMALE; GENOTYPE; HUMAN; HUMAN CELL; KOREAN MEDICINE; MAJOR CLINICAL STUDY; PAPILLOMAVIRUS INFECTION; REVERSE BLOT HYBRIDIZATION ASSAY; SEQUENCE ANALYSIS; SOUTH KOREA; VIRUS DETECTION; VIRUS TYPING; WART VIRUS;

CARCINOMA, SQUAMOUS CELL; CERVICAL INTRAEPITHELIAL NEOPLASIA; DNA, VIRAL; FEMALE; GENOTYPE; HUMANS; NUCLEIC ACID HYBRIDIZATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; REPUBLIC OF KOREA; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 84862695185     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.23334     Document Type: Article

References (12)

1. Bohmer G, van den Brule AJ, Brummer O, Meijer CL, Petry KU. 2003. No confirmed case of human papillomavirus DNA negative cervical intraepithelial neoplasia Grade 3 or invasive primary cancer of the uterine cervix among 511 patients. Am J Obstet Gynecol 189: 118-120.
2. Bosch FX, Lorincz A, Munoz N, Meijer CJ, Shah KV. 2002. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 55: 244-265.
3. De Villiers EM, Fauquet C, Broker TR, Bernard HU, Zur Hausen H. 2004. Classification of papillomaviruses. Virology 324: 17-27.
4. Fatima GS, Rodriguez-Iglesias MA. 2009. Comparison of human papillomavirus genotyping using commercial assays based on PCR and reverse hybridization methods. APMIS 117: 708-715.
5. Hong SR, Kim IS, Kim DW, Kim MJ, Kim AR, Kim YO, Kim HS. 2009. Prevalence and genotype distribution of cervical human papillomavirus DNA in Korean women: A multicenter study. Kor J Pathol 43: 342-350.
6. Kang WD, Kim CH, Cho MK, Kim JW, Kim YH, Choi HS, Kim SM. 2009. Comparison of the hybrid capture II assay with the human papillomavirus DNA chip test for the detection of high-grade cervical lesions. Int J Gynecol Cancer 19: 924-928.
7. Roden R, Wu TC. 2006. How will HPV vaccines affect cervical cancer? Nat Rev Cancer 6: 753-763.
8. Schiffman MH, Bauer HM, Hoover RN, Glass AG, Cadell DM, Rush BB. 1993. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J Natl Cancer Inst 85: 958-964.
9. Schudel BR, Tanyeri M, Mukherjee A, Schroeder CM, Kenis PJ. 2011. Multiplexed detection of nucleic acids in a combinatorial screening chip. Lab Chip 11: 1916-1923.
10. Thomas I, Liesje G, Ryan S. 1999. Development and clinical evaluation of a highly sensitive PCR-reverse hybridization line probe assay for detection and identification of anogenital human papillomavirus. J Clin Microbiol 37: 2508-2517.
11. Vecchio G, Sabella S, Tagliaferro L, Menegazzi P, Di Bello MP, Brunetti V, Cingolani R, Rinaldi R, Pompa PP. 2010. Modular plastic chip for one-shot human papillomavirus diagnostic analysis. Anal Biochem 397: 53-59.
12. Walboomers JMM, Jacobs MV, Manos MM, Bosch FX, Kummer A, Shah KV, Snijders PJF. 1999. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189: 12-19.